Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Net Income towards Common Stockholders Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
275.44 Mn |
270.68 Mn |
- |
-116.75% |
| Date | Value |
|---|
| Mar 31, 2026 |
-116.75% |
| Dec 31, 2025 |
-21.84% |
| Sep 30, 2025 |
-12.06% |
| Jun 30, 2025 |
-20.93% |
| Mar 31, 2025 |
-10.17% |
| Dec 31, 2024 |
-31.72% |
| Sep 30, 2024 |
-27.31% |
| Jun 30, 2024 |
-32.51% |
| Mar 31, 2024 |
-65.75% |
| Dec 31, 2023 |
-18.71% |
| Sep 30, 2023 |
-25.73% |
| Jun 30, 2023 |
-26.71% |
| Mar 31, 2023 |
-30.66% |
| Dec 31, 2022 |
-31.02% |
| Sep 30, 2022 |
-7.39% |
| Jun 30, 2022 |
-29.95% |
| Mar 31, 2022 |
-34.36% |
| Dec 31, 2021 |
12.13% |
| Sep 30, 2021 |
-55.73% |
| Jun 30, 2021 |
-26.64% |
